No Cover Image

Journal article 805 views

A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer

Fabrizio Pertusati, Salvatore Ferla Orcid Logo, Marcella Bassetto, Andrea Brancale, Sahar Khandil, Andrew D. Westwell, Christopher McGuigan

European Journal of Medicinal Chemistry, Volume: 180, Pages: 1 - 14

Swansea University Authors: Salvatore Ferla Orcid Logo, Marcella Bassetto

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.1016/j.ejmech.2019.07.001

Published in: European Journal of Medicinal Chemistry
ISSN: 0223-5234
Published: Elsevier BV 2019
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa52218
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2019-10-01T20:18:38Z
last_indexed 2020-11-06T04:12:41Z
id cronfa52218
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2020-11-05T17:09:52.0164718</datestamp><bib-version>v2</bib-version><id>52218</id><entry>2019-10-01</entry><title>A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer</title><swanseaauthors><author><sid>d4c62248f510e3b221916989a7bbe6a6</sid><ORCID>0000-0002-5918-9237</ORCID><firstname>Salvatore</firstname><surname>Ferla</surname><name>Salvatore Ferla</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b97beeed16f8e0524551233ade909565</sid><firstname>Marcella</firstname><surname>Bassetto</surname><name>Marcella Bassetto</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2019-10-01</date><deptcode>PHAR</deptcode><abstract/><type>Journal Article</type><journal>European Journal of Medicinal Chemistry</journal><volume>180</volume><journalNumber/><paginationStart>1</paginationStart><paginationEnd>14</paginationEnd><publisher>Elsevier BV</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0223-5234</issnPrint><issnElectronic/><keywords>Pentafluorosulfanyl; Pentafluoroethyl; Prostate cancer; Androgen receptor; Antiproliferative activity; Enobosarm; Bicalutamide; Enzalutamide</keywords><publishedDay>15</publishedDay><publishedMonth>10</publishedMonth><publishedYear>2019</publishedYear><publishedDate>2019-10-15</publishedDate><doi>10.1016/j.ejmech.2019.07.001</doi><url>http://orca.cf.ac.uk/124785/</url><notes/><college>COLLEGE NANME</college><department>Pharmacy</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>PHAR</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-11-05T17:09:52.0164718</lastEdited><Created>2019-10-01T19:12:47.3489509</Created><path><level id="1">Faculty of Science and Engineering</level><level id="2">School of Engineering and Applied Sciences - Chemistry</level></path><authors><author><firstname>Fabrizio</firstname><surname>Pertusati</surname><order>1</order></author><author><firstname>Salvatore</firstname><surname>Ferla</surname><orcid>0000-0002-5918-9237</orcid><order>2</order></author><author><firstname>Marcella</firstname><surname>Bassetto</surname><order>3</order></author><author><firstname>Andrea</firstname><surname>Brancale</surname><order>4</order></author><author><firstname>Sahar</firstname><surname>Khandil</surname><order>5</order></author><author><firstname>Andrew D.</firstname><surname>Westwell</surname><order>6</order></author><author><firstname>Christopher</firstname><surname>McGuigan</surname><order>7</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2020-11-05T17:09:52.0164718 v2 52218 2019-10-01 A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer d4c62248f510e3b221916989a7bbe6a6 0000-0002-5918-9237 Salvatore Ferla Salvatore Ferla true false b97beeed16f8e0524551233ade909565 Marcella Bassetto Marcella Bassetto true false 2019-10-01 PHAR Journal Article European Journal of Medicinal Chemistry 180 1 14 Elsevier BV 0223-5234 Pentafluorosulfanyl; Pentafluoroethyl; Prostate cancer; Androgen receptor; Antiproliferative activity; Enobosarm; Bicalutamide; Enzalutamide 15 10 2019 2019-10-15 10.1016/j.ejmech.2019.07.001 http://orca.cf.ac.uk/124785/ COLLEGE NANME Pharmacy COLLEGE CODE PHAR Swansea University 2020-11-05T17:09:52.0164718 2019-10-01T19:12:47.3489509 Faculty of Science and Engineering School of Engineering and Applied Sciences - Chemistry Fabrizio Pertusati 1 Salvatore Ferla 0000-0002-5918-9237 2 Marcella Bassetto 3 Andrea Brancale 4 Sahar Khandil 5 Andrew D. Westwell 6 Christopher McGuigan 7
title A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer
spellingShingle A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer
Salvatore Ferla
Marcella Bassetto
title_short A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer
title_full A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer
title_fullStr A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer
title_full_unstemmed A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer
title_sort A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer
author_id_str_mv d4c62248f510e3b221916989a7bbe6a6
b97beeed16f8e0524551233ade909565
author_id_fullname_str_mv d4c62248f510e3b221916989a7bbe6a6_***_Salvatore Ferla
b97beeed16f8e0524551233ade909565_***_Marcella Bassetto
author Salvatore Ferla
Marcella Bassetto
author2 Fabrizio Pertusati
Salvatore Ferla
Marcella Bassetto
Andrea Brancale
Sahar Khandil
Andrew D. Westwell
Christopher McGuigan
format Journal article
container_title European Journal of Medicinal Chemistry
container_volume 180
container_start_page 1
publishDate 2019
institution Swansea University
issn 0223-5234
doi_str_mv 10.1016/j.ejmech.2019.07.001
publisher Elsevier BV
college_str Faculty of Science and Engineering
hierarchytype
hierarchy_top_id facultyofscienceandengineering
hierarchy_top_title Faculty of Science and Engineering
hierarchy_parent_id facultyofscienceandengineering
hierarchy_parent_title Faculty of Science and Engineering
department_str School of Engineering and Applied Sciences - Chemistry{{{_:::_}}}Faculty of Science and Engineering{{{_:::_}}}School of Engineering and Applied Sciences - Chemistry
url http://orca.cf.ac.uk/124785/
document_store_str 0
active_str 0
published_date 2019-10-15T04:04:27Z
_version_ 1763753347407413248
score 11.012678

Similar Items